Clinical Trial Update: Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for MYOBLOC in adult upper limb spasticity across Phase 2 and Phase 3, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• MYOBLOC (rimabotulinumtoxinB)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Spasticity, Cerebrovascular Accident | Phase 2, Phase 3 | Status: UNKNOWN